The HemOnc Pulse cover image

Krish Patel, MD, Talks Glofitamab, Other Novel Therapies in DLBCL

The HemOnc Pulse

00:00

Comparing Side Effects and Quality of Life Impact of Novel Therapy in DLBCL

Exploration of the side effects and accessibility of a novel therapy compared to CAR-T therapy. Focus on lower-grade CRS, step-up dosing strategy for risk management, and enhanced accessibility in community sites for improved quality of life.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app